Clinical Trial

Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial

Study acronym: MIFA-ACT
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is an open-label individually randomized mixed methods cross-over trial to assess acceptability, preference, and side effects of IFA formulations with 60 mg of iron to MMS formulations with 60 mg of iron.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09-01 -> 2027-12-01 2026-06-05
minor Completion pushed: 2026-12 -> 2027-12 2026-06-05
Trial Details
NCT Number NCT06069856
Lead Sponsor George Washington University
Collaborators: Ifakara Health Institute, Harvard School of Public Health (HSPH), Muhimbili University of Health and Allied Sciences, Africa Academy for Public Health, Columbia University
Conditions Pregnancy Related
Enrollment 130 participants
Start Date 2027-06-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-04